Drug intelligence / Profile preview

Shenlinglan Capsule

Development stage
Unknown
Lead developer
Yiling Pharmaceutical
Administration
Oral
01

Overview

Shenlinglan Capsule is a patented Traditional Chinese Medicine (TCM) developed by Shijiazhuang Yiling Pharmaceutical. It is approved in China for the treatment of urologic diseases, specifically benign prostatic hyperplasia (BPH) and as an adjuvant therapy for prostate cancer. The formulation is designed to tonify Qi, nourish Yin, and resolve blood stasis, which are common pathological patterns in chronic prostate conditions according to TCM principles. It is composed of several botanical extracts, including Ginseng (*Panax ginseng*), Ganoderma (*Ganoderma lucidum*), and Isatis (*Isatis indigotica*).

Brand names
Shenlinglan Capsule
Other names
Shenlinglan Jiaonang参灵蓝胶囊
02

Targets

IR/IGF-1R (Insulin receptor / Insulin-like growth factor 1 receptor)KLF5 (Krüppel-like factor 5)SPHK1 (Sphingosine kinase 1)GSK3 (Glycogen synthase kinase 3 beta)AKR1B10 (Aldo-keto reductase family 1 member B10)PPARG (Peroxisome proliferator-activated receptor gamma)

Beyond the preview

Go deeper on Shenlinglan Capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shenlinglan Capsule.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call